A Clinical Trial Study of Knee System in Primary Total Knee Arthroplasty in China
A Prospective, Randomized, Multicenter, Controlled Study Comparing the Outcomes of Primary Total Knee Arthroplasty Devices Manufactured in China Versus Devices Manufactured Outside of China
Sponsor: Johnson & Johnson Medical (Suzhou) Ltd.
This NA trial investigates Arthritis, Rheumatoid and Osteoarthritis and is currently completed. Johnson & Johnson Medical (Suzhou) Ltd. leads this study, which shows 8 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Dec 2019 — Jan 2021 [monthly]
Completed NA
Status: Recruiting → Completed
▶ Show 3 earlier versions
-
Jun 2018 — Dec 2019 [monthly]
Recruiting NA
-
Dec 2017 — Jun 2018 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting · Phase: PHASE3 → NA
-
Jan 2017 — Dec 2017 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Johnson & Johnson Medical (Suzhou) Ltd.
For direct contact, visit the study record on ClinicalTrials.gov .